Latest news updates

2023-04-14

Welcome Polyxeni - Director of Immunology

Introducing yet another recent addition to our team! In March, Polyxeni Mantani joined Redoxis taking on the role as Director of Immunology.

2023-04-13

We’re hiring!

Redoxis is searching for the next colleagues to join our team. This time we are looking for a Scientist In Vivo and a Senior Scientist In Vitro. Read more using the link below and apply on our careers page. We are welcoming applications until the 14th of April.

2023-04-13

Redoxis keeps expanding!

Recently Fredrik Berglind joined our crew of highly competent and dedicated #researchers. We are very happy to have him on board and with his background and expertise in #neurodegenerative diseases he will complement and strengthen our #service capacities for continuous strive for excellence!

2023-01-27

SmiLe Incubator 15 year celebration!

Congratulations SmiLe Incubator and thanks for the support during the years! Being part of the incubator setting with support, network and availability of laboratory equipment was crucial during the early years of Redoxis as well as now as an alumni member.

2023-01-17

Half time seminar

Yesterday, Alex Moreno, who is pursuing his industrial PhD at Redoxis in collaboration with Karolinska Institutet, held his half time defense in Stockholm.

2023-01-05

Good luck Francesco!

It is equally important to acknowledge a coworker leaving as it is celebrating new colleagues joining our team.

2022-12-20

Christmas meeting & dinner

Yesterday we had our last meeting before the holidays to sum up this fantastic year, followed by a lovely dinner in Malmö.

2022-12-13

SwedenBIO summit 2022

Last week, Malin Hultqvist Hopkins and Nina Woodworth attended the SwedenBIO summit 2022 in Stockholm. The annual event where this year, lifescience leaders were gathered to discuss around financing, recruitment and IP strategy, share latest news and network.

2022-12-09

The team is expanding

Better late than never, we would like to present two of our latest additions to the Redoxis team! Before the summer we had Elin Benatti and Kedir Hussen Hamza join or crew of highly competent and dedicated researchers.

2022-09-21

Redox Alterations and Cellular Responses

This week, our Linda Reimer Rasmusson is attending the FEBS Advanced Lecture Course on the topic "Redox Alterations and Cellular Responses" sponsored by Redoxis AB and taking place on the beautiful Spetses Island in Greece.

2022-02-02

New model description available

We recently released a new model description of our DSS induced Colitis model in mice. This model is a good tool for investigation of effects of novel therapies for Chron Disease and Ulcerative Colitis. DSS in drinking water induces intestinal inflammation allowing pro inflammatory intestinal content into the underlying tissue.

2021-01-18

Redoxis signs license agreement with VivoLogica

Redoxis AB recently signed a license agreement with VivoLogica for use of their software platform for in vivo study management. This is an important step in our journey and aim to provide highest quality data in all our preclinical projects. We are looking forward to our continued collaboration with the VivoLogica team.

2021-01-11

Redoxis and Amarna Therapeutics receive EUREKA Eurostars grant for project ALPHAVAC

We are happy to announce that Redoxis, together with our Dutch partner Amarna Therapeutics has been awarded a €0,8 million grant from EUREKA Eurostars to establish a screening platform for the advancement of potential first-in-class gene therapy for ALS and other neurodegenerative diseases using Amarna´s proprietary SVec viral vector platform.

2021-05-18

Redoxis in collaborative project to study inflammation in vascular disease

We are happy to announce that Redoxis AB is a partner in a research project called “Targeting he melanocortin system as a novel strategy to reduce inflammation during vascular disease” led by Senior Lecturer Liza Ljungberg, School of Medical Sciences at Örebro University. The project was funded by a research grant of SEK 4 million from The Knowledge Foundation, funding research and competence development at Swedish universities. Redoxis will contribute to the project, that is planned to start 1st of July 2021, with expertise in preclinical drug development and efficacy assessment in both disease models and functional assays. “Participating in this project is in line with Redoxis aim to continuously expand competence area, implement new clinically relevant models and stay closely connected with academic research in our quest to be the best contract research organization in preclinical inflammatory research” says Malin Hultqvist Hopkins, CEO of Redoxis AB The project is a collaboration between Örebro University, SynAct Pharma AB and Redoxis AB.

2021-02-04

Redoxis is once again accredited for CIR (French Research Tax Reduction)

Redoxis has been granted approval for the French research tax credit (CIR) for 2021, 2022 and 2023 from the French Ministry of Higher Education and R...

2021-01-20

We are increasing our In Vitro service capacity

This week we are welcoming Linda Reimer Rasmusson back to Redoxis. Linda started her carreer at Redoxis and is now returning to strengthen our In Vit...

2021-01-14

Welcome Tekla!

The newest addition to our team is Tekla Franzén. Tekla is a trained animal technician and held her the most recent position at the Lund University a...

2020-12-21

Seasons greetings

...

2020-09-11

Are you our new collegue?

We have an open position for a laboratory technician with focus on in vivo work (försöksdjurstekniker). Read more here or contact us directly for mor...

2020-07-21

Models of cytokine release for evaluation of efficacy in acute innate inflammatory responses

Recently, much attention has been given the role of proinflammatory cytokines in pathology of COVID-19. Massive release of cytokines, cytokine storm,...

2020-06-24

Redoxis announces approved Eurostars funding for project E!114520 - ACTION

We are very happy to announce that our joint project application E!114520 ACTION has been approved as a Eurostars labelled project and funding by the...

2020-06-08

We are growing even stronger

A warm welcome to Jens Holmberg, PhD, the latest addition to our team. Jens has a background in preclinical inflammation research with extensive expe...

2020-05-20

Cell based 3D immunology assays: mimicking in vivo structures in models of inflammation

We are continuously adding more assays and models to our portfolio while also actively improving our current models. In collaboration with Cellevate ...

2020-04-23

Redoxis AB signs a 3-year agreement with Taconic Biosciences, Inc.

Redoxis AB has signed an agreement with Taconic Biosciences, Inc for service of characterization of cellular composition of Taconic’s humanized immun...

2020-04-20

Registered US trademark

As of beginning of March, Redoxis is now a registered trademark in the US. Redoxis has previously been a registered trademark in Sweden and European ...

2020-04-14

We are fully operational

The current Covid-19 situation is clearly affecting all of us but Redoxis CRO services are still fully operational. In addition to our already valida...

2020-03-18

Redoxis´ first PhD student

Alex Moreno joined our company fall of 2018 as an early stage researcher through the European Training Network COSMIC, funded from the European Union...

2020-03-26

Master project available

Successful translation of in vitro results to in vivo proof of concept data is essential in early drug development. Traditionally, in vitro models ha...

2020-03-16

New lab celebration

In the end of December, Redoxis moved into new lab facilities within Medicon Village. With increased lab space and more offices, the new facilities a...

2020-02-11

NeutroCure kick-off meeting

Last week, we successfully kicked off the Horizon 2020 funded FETOPEN program NeutroCure (agreement No 861878). The consortium, with partners from Fr...

2020-01-23

Eurostars Butterfly project meeting

The H2020 funded Eurostars project BUTTERFLY (E! 12979) is well off and in full speed ahead. This week we had a joint meeting with the collaborating ...

2019-12-06

BioFit 2019

Next week, our Senior scientist PhD Francesco Bez will be at the BioFit meeting in Marseille. Francesco is specialising in neurodegenerative diseases...

2019-12-04

Educational day with Redoxis founders

We started off this week with an educational day including presentations from Professor Rikard Holmdahl and Peter Olofsson on Redoxis background and ...

2019-11-26

Standardized preparation of emulsions results in less variation in vivo - a collaboration with BTB Emulsions

As part of our internal efforts to standardize in vivo models to decrease inter-experimental variations, we have evaluated the POWER emulsion prepara...

2019-11-15

Pharma Outsourcing 2019

Come and meet with us during the annual Pharma outsourcing meeting in Stockholm taking place the 10th of December. The meeting includes both presenta...

2019-11-11

Bio-Europe 2019

This week we are excited to attend the 25th edition of Bio-Europe. Redoxis is represented by CEO Malin Hultqvist Hopkins and we are looking forward to...

2019-10-20

Publication on effects of ROS on handling of necrotic cells

Recently, our manuscript "NOX2 mediates quiescent handling of dead cell remnants in phagocytes" was published in Redox Biology. The paper describes th...

2019-10-09

Redoxis receives Horizon 2020 grant

The FET Open Horizon 2020 project under acronym NeutroCure, in which Redoxis is one of the partners, has been granted by the EU commission. The projec...

2019-09-25

BioPharm America

During September, CEO Malin Hultqvist Hopkins attended the BioPharm America partnering meeting in Boston, MA. This was the first meeting attended by R...

2019-03-13

BioEurope spring 2019

We are in full preparation for the BioEurope spring in Wienna taking place 25th to 27th March. We will be happy to catch up on your needs for preclini...

2019-03-12

Open position

We are looking for a new member of our in vivo team. Preferably you have a background with preclinical inflammation models and contract research. For ...

2018-10-26

Meet us att BioEurope

Redoxis will be represented at BioEurope taking place in Copenhagen 5-7th of November. Come meet us at our stand (#110) or book a one-to-one meeting t...

2018-09-12

Redoxis receives CIR (French Research Tax Credit) accreditation

Redoxis has been granted approval for the French research tax credit (CIR) for 2018, 2019 and 2020 from the French Ministry of Higher Education and Re...

2018-09-07

Nordic life science days 2018

Next week Malin Hultqvist Hopkins (CEO) will be at the Nordic Life Science days (NLS days) in Stockholm. Get in touch if you are attending and would l...

2018-09-07

Brain Gain

Redoxis is today at Brain Gain Sweden! Francesco Bez is a speaker during the innovation panel (aging brain disorders) presenting our latest developmen...

2018-07-05

Meet us at the 11th FENS forum of Neuroscience

Francesco Bez will attend the FENS forum of neuroscience taking place in Berlin on the 7-11 of July. We continuously add more models to our portfolio ...

2018-06-29

Redoxis annual summer meeting

Yesterday, Redoxis had its annual summer meeting with many fruitful discussions followed by a tough contest (you might see who was on the winning team...

2018-06-01

Society for free radical research international biannual meeting

As part of the RISE project REDOXIT (Marie Sklodowska-Curie Action) we are present at the SFRRI meeting in Lisbon next week. By attending this meeting...

2018-05-11

Meet us at the Global Discovery to Development Innovation Forum

Francesco Bez will be present at the 11th Global Discovery to Development Innovation Forum (GDDIF) taking place in Amsterdam 16-17th of May. We contin...

2018-05-11

Magnetic resonance imaging in animal models

Established under the Eurostars E9215 (IMAID) program, Redoxis can now offer magnetic resonance imaging services in animal models. Redoxis offer, toge...

2018-03-02

Meet us at BioEurope Spring

Malin H Hopkins (CEO) will be present at BioEurope Spring taking place in Amsterdam 12-14th of March. We continuously add more models to our portfolio...

2018-03-01

NEW - In vivo models of Psoriasis and Psoriatic arthritis

Redoxis is now proud to offer models of Psoriasis (IMQ model) and Psoriatic Arthritis (MiP) model. Psoriasis is a common autoimmune disease affecting ...

2018-02-23

Newest member of our team - Frida

We are, since december, happy to have Frida on our team of researchers. Frida just finished her master in molecular biology at the University of Lund ...

2018-02-20

Applications invited

Applications are invited for 14 ESRs (Early Stage Researchers) funded by the Marie-Sklodowska-Curie Innovative Training Network COSMIC (Combatting dis...

2018-01-25

Redoxis a part of COSMIC

As of the first of January 2018 Redoxis is a part of the international consortium COSMIC. COSMIC systems medicine training and research programme kic...

2017-10-31

Meet us at BioEurope 6-8 November, Berlin

We will be at the BioEurope meeting in Berlin from 6-8 of November. Take the opportunity to meet with us for a presentation of our services and models...

2017-09-25

Want to join our team?

We are looking to expand our team with a person experienced in laboratory work and preclinical in vivo models of inflammatory diseases. More informati...

2017-07-07

NEW - LPS induced acute inflammation in mice

We are continuously adding new, well characterised models to our portfolio and the latest is the LPS induced acute inflammation model in mice. Mice ar...

2017-07-06

Nordic Life Science days 2017

Redoxis will be represented by Sebastian Hansson at the Nordic Life Science (NLS) days in Malmö/Copenhagen the 12th-14th September. Sebastian will be ...

2017-06-22

Meet Sebastian

Since June this year, we are happy to have Sebastian Hansson, Business Development Manager, joint our team. Sebastian will strengthen our competence w...

2017-06-12

We are welcoming Francesco Bez to our team

Starting today, we are happy to have Francesco Bez (PhD) joining our team. Francesco holds a PhD in Neuroscience and is an expert in in vivo models of...

2017-03-24

Meet us at the Future of Swedish and Danish life science days

The future of Swedish and Danish life science days will be taking place the 30th of March at Medicon village in Lund. Redoxis will be represented with...

2017-03-24

BioEurope Spring 2017

Redoxis attended the BioEurope spring partnering meeting in Barcelona 20-22 March. During this successful event we enjoyed meetings with new partners ...

2017-01-26

5-year celebration with Medicon Village

Friday the 20th of January, Medicon Village hosted a large event to celebrate their first 5-years. Their success have been enormous and plans for the ...

2016-11-04

Published paper on effects of cytokines using our rat ex vivo model

The electronic version of our manuscript "Cytokine correlation analysis based on drug perturbation" was recently accepted published after acceptance i...

2016-11-02

Meet us at BioEurope in Cologne 7-9 Nov

Redoxis will, as a part of a delegation of innovative life science companies from Skåne, together with Invest in Skåne participate in the partnering m...

2016-06-01

Pristane induced arthritis (PIA) in focus

Innovative Medicines Initiative BTCure, in which Redoxis is a partner, has combined experience from laboratories worldwide to establish standardised p...

2016-05-12

New CEO

Since May 1st Malin Hultqvist Hopkins, former CSO, is appointed CEO of Redoxis. This change is in line with Redoxis continuous ambition to be a focuse...

2016-04-04

BioEurope is finally in Stockholm

Since BioEurope is one of the main events for partnering and drug development collaborations, Redoxis is during 4-6 April in Stockholm attending the B...

2015-12-16

We are expanding our in vitro/ex vivo analysis capacity

At Redoxis, we have a fully equipped lab for work with both primary cells and cell lines. We also hava fully equipped laboratory for post experiment f...

2015-11-10

Pharmaoutsourcing in Stockholm 9th December

In the 9th of December we will attend the PHARMA OUTSOURCING meeting in Stockholm- This is a new annual international partnering meeting for Investme...

2015-11-07

NEURINOX gathers top researchers, patients and industry in an international symposium on innovative concepts for treating neurodegenerative diseases

Neurodegeneration leads to chronic debilitating diseases, including age-related syndromes like Alzheimer's and Parkinson's diseases and disorders affe...

2015-09-09

Meeting partners and NLS days in Stockholm 9-10 september

Attending one of the largest partnering event in Life Science, these days taking place in Stockholm 9-10 September- 2015. This will be an event not on...

2015-09-01

Tax reduction eligibility for Redoxis services

Redoxis has been approved by the French authorities "Ministère chargé de l'Enseignement supérieur et de la Recherche" eligible for tax reduction for s...

2015-08-19

RISE - European collaboration with Aston University and University of Erlangen

This month we started the RISE project REDOXIT for Research and Innovation Staff Exchange (RISE) as a collaborative project with Aston University (Bir...

Customised Services in Preclinical Inflammation

News